SEC Comment Letter 0000000000-24-008604 to SOLIGENIX, INC. (SNGX)
SOLIGENIX, INC.
Date: July 29, 2024 · CIK: 0000812796 · Accession: 0000000000-24-008604
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-280993
Letter
July 29, 2024 Christopher Schaber Chief Executive Officer Soligenix, Inc. 29 Emmons Drive, Suite B-10 Princeton, NJ 08540 Re:Soligenix, Inc. Registration Statement on Form S-1 Filed July 24, 2024 File No. 333-280993 Dear Christopher Schaber: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Driscoll R. Ugarte
Show Raw Text
July 29, 2024
Christopher Schaber
Chief Executive Officer
Soligenix, Inc.
29 Emmons Drive, Suite B-10
Princeton, NJ 08540
Re:Soligenix, Inc.
Registration Statement on Form S-1
Filed July 24, 2024
File No. 333-280993
Dear Christopher Schaber:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Driscoll R. Ugarte